| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/03/1998 | WO1998038309A1 Clavaspirins |
| 09/03/1998 | WO1998038307A1 Novel human transmembrane 4 superfamily protein |
| 09/03/1998 | WO1998038305A1 Physiologically active protein originating in mammals |
| 09/03/1998 | WO1998038304A1 Novel polypeptide, dna encoding the same and use thereof |
| 09/03/1998 | WO1998038303A1 Procollagen assembly |
| 09/03/1998 | WO1998038302A2 TETRODOTOXIN-SENSITIVE SODIUM CHANNEL α-SUBUNIT |
| 09/03/1998 | WO1998038300A1 Circular dna vectors for synthesis of rna and dna |
| 09/03/1998 | WO1998038291A1 Component of bromelain |
| 09/03/1998 | WO1998038220A1 Method for purifying factor viii/vwf complex by cation-exchange chromatography |
| 09/03/1998 | WO1998038219A1 Purification of von willebrand factor by cation exhcanger chromatography |
| 09/03/1998 | WO1998038218A1 Method for obtaining high-purity vwf or factor viii/vwf complex |
| 09/03/1998 | WO1998038216A1 Cell surface molecule mediating cell adhesion and signal transmission |
| 09/03/1998 | WO1998038215A1 Beta-endorphin peptides for treating muscle-wasting diseases |
| 09/03/1998 | WO1998038214A1 Heparan sulfate/heparin interacting protein compositions and methods of use |
| 09/03/1998 | WO1998038213A1 Intracellular signal transmission inhibitor |
| 09/03/1998 | WO1998038212A2 Chimeric polypeptides containing chemokine domains |
| 09/03/1998 | WO1998038211A2 Permuted hemoglobin-like proteins |
| 09/03/1998 | WO1998038210A2 Methods and compositions for modulation of vesicular release |
| 09/03/1998 | WO1998038200A1 Nucleic acids encoding caspase-8h and caspase-8i |
| 09/03/1998 | WO1998037918A1 Staphylococcus 3-dehydroquinate synthase |
| 09/03/1998 | WO1998037917A1 Novel processes implementing selective immune down regulation (sidr) |
| 09/03/1998 | WO1998037914A1 Remedies for hepatitis |
| 09/03/1998 | WO1998037913A1 Lymphocyte activation inhibitors |
| 09/03/1998 | WO1998037909A1 Methods and compositions for optimization of oxygen transport by cell-free systems |
| 09/03/1998 | WO1998037908A1 The use of heme-peptides to prevent or retard disease associated with oxidative stress |
| 09/03/1998 | WO1998037907A1 Protection of living systems from the adverse effects of stress |
| 09/03/1998 | WO1998037901A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 09/03/1998 | WO1998037773A1 Process for preparing a nutritional supplement |
| 09/03/1998 | WO1998029566A3 Novel method for testing the differentiation status in pancreatic cells of a mammal |
| 09/03/1998 | WO1998029436A3 Lebetin peptides as platelet aggregation inhibitors |
| 09/03/1998 | WO1998028423A3 Compositions and methods of use for osteoclast inhibitory factors |
| 09/03/1998 | WO1998024910A3 Mutants of streptococcal toxin c and methods of use |
| 09/03/1998 | WO1998024804A3 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
| 09/03/1998 | WO1998022608A3 Post-mitotic neurons containing adenovirus vectors that modulate apoptosis and growth |
| 09/03/1998 | WO1998018942A3 Novel human rab proteins |
| 09/03/1998 | WO1998016205A3 Stable glassy state powder formulations |
| 09/03/1998 | WO1998012327A3 Compositions and methods comprising bard1 and other brca1 binding proteins |
| 09/03/1998 | DE19808452A1 Composition for treating degenerative diseases of retina |
| 09/03/1998 | DE19726626C1 Preparation of composition comprising purified hyaluronidase |
| 09/03/1998 | DE19707854A1 New cyclic peptides used as antiarrhythmic agents |
| 09/03/1998 | CA2283107A1 A tm4sf human tumor-associated antigen |
| 09/03/1998 | CA2282736A1 Novel human transmembrane 4 superfamily protein |
| 09/03/1998 | CA2282728A1 Factor x deletion mutants and analogues thereof |
| 09/03/1998 | CA2282707A1 Factor x analogues with a modified protease cleavage site |
| 09/03/1998 | CA2282631A1 Lymphocyte activation inhibitors |
| 09/03/1998 | CA2282557A1 Physiologically active protein originating in mammals |
| 09/03/1998 | CA2281567A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 09/03/1998 | CA2252790A1 Novel processes implementing selective immune down regulation (sidr) |
| 09/03/1998 | CA2252629A1 Remedies for hepatitis |
| 09/03/1998 | CA2252625A1 Chimeric cell-surface receptors that undergo antigen-induced association |
| 09/03/1998 | CA2247072A1 Bacterial elastin binding protein, nucleic acid sequence encoding same and diagnostic and therapeutic methods of use thereof |
| 09/03/1998 | CA2198988A1 P28 bap31 a bcl-2 associated protein and use thereof for the modulation of apoptosis |
| 09/02/1998 | EP0861900A1 Immunological detection of prions |
| 09/02/1998 | EP0861899A1 LicA polypeptides from Sreptococcus pneumoniae |
| 09/02/1998 | EP0861898A1 Rat Cathepsin K polynucleotide & polypeptide sequence |
| 09/02/1998 | EP0861897A2 Recombinant bile salt activated lipases |
| 09/02/1998 | EP0861896A2 Cell volume regulated human kinase h-sgk |
| 09/02/1998 | EP0861895A2 aroE shikimate 5 dehydrogenase from Staphylococcus Aureus |
| 09/02/1998 | EP0861894A1 Differentiation-suppressive polypeptide |
| 09/02/1998 | EP0861892A1 Stress protein epitopes |
| 09/02/1998 | EP0861891A1 Compounds for modulating cell negative regulations and biological applications thereof |
| 09/02/1998 | EP0861890A1 LicC polypeptides from Streptococcus pneumoniae |
| 09/02/1998 | EP0861889A1 LicD2 polypeptides from Streptococcus pneumoniae |
| 09/02/1998 | EP0861888A1 Use of crosslinked crystals as a novel form of enzyme immobilization |
| 09/02/1998 | EP0861851A1 Lys (B28) insulins. Human insulin analogues |
| 09/02/1998 | EP0861850A1 Tumor necrosis related receptor, TR4 |
| 09/02/1998 | EP0861849A1 Peptide derivatives |
| 09/02/1998 | EP0861664A2 Vaccine against Lyme disease |
| 09/02/1998 | EP0861663A2 Osteoclastgenic inhibitory agent comprising interleukin-18 |
| 09/02/1998 | EP0861440A1 Recombinant proteins having multiple disulfide bonds and thiol-substituted conjugates thereof |
| 09/02/1998 | EP0861326A1 Hybrid factor viii with modified activity |
| 09/02/1998 | EP0861322A1 Antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for replication |
| 09/02/1998 | EP0861321A2 Phosphopantetheinyl transferases and uses thereof |
| 09/02/1998 | EP0861320A1 Sequestrin |
| 09/02/1998 | EP0861319A1 Immunity against actinobacillus pleuropneumoniae's rtx toxins apx |
| 09/02/1998 | EP0861267A1 Inducing resistance to tumor growth with soluble igf-1 receptor |
| 09/02/1998 | EP0861266A1 Peptide conjugates derived from thymic hormones, their use as medicament and compositions containing them |
| 09/02/1998 | EP0861265A1 Casein fragments having growth promoting activity |
| 09/02/1998 | EP0861263A1 The transcriptional promoter of the obesity gene |
| 09/02/1998 | EP0861261A1 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 09/02/1998 | EP0861260A1 Improved method and agents for inhibiting protein aging |
| 09/02/1998 | EP0861228A1 Lipopolyamines as transfection agents and pharmaceutical uses thereof |
| 09/02/1998 | EP0861092A1 Therapy for cellular accumulation in chronic inflammatory diseases |
| 09/02/1998 | EP0861091A1 Immunotoxin containing a disulfide-stabilized antibody fragment |
| 09/02/1998 | EP0861089A2 Methods and compositions for the delivery of monomeric proteins |
| 09/02/1998 | EP0861088A1 Bactericidal permeability increasing protein (bpi) for treating conditions associated with corneal injury |
| 09/02/1998 | EP0861087A1 Bactericidal/permeability increasing protein (bpi) for treating conditions associated with corneal transplantation |
| 09/02/1998 | EP0861086A1 Type ix collagen and chimeras |
| 09/02/1998 | EP0861082A1 Therapy for tissue membrane insufficiency |
| 09/02/1998 | EP0861072A2 Compositions for the treatment of blood disorders |
| 09/02/1998 | EP0861027A1 IceA GENE AND RELATED METHODS |
| 09/02/1998 | EP0770128A4 Ikaros transgenic cells and animals |
| 09/02/1998 | EP0766696B1 Thiazolidine derivatives, their preparation and drugs containing same |
| 09/02/1998 | EP0716659A4 Epiligrin, an epithelial ligand for integrins |
| 09/02/1998 | EP0705276B1 Prostaglandin receptor fp and dna encoding it |
| 09/02/1998 | EP0686044B1 Inhibition of intimal hyperplasia using antibodies to pdgf receptors |
| 09/02/1998 | EP0674716B1 Retroviral vectors for the treatment of tumors, and cell lines containing them |
| 09/02/1998 | EP0636173B1 Treatment of hiv-associated immune thrombocytopenic purpura |
| 09/02/1998 | EP0606217B1 Ctl4a receptor, fusion proteins containing it and uses thereof |
| 09/02/1998 | EP0594610B1 PROTEIN D - AN IgD-BINDING PROTEIN OF HAEMOPHILUS INFLUENZAE |